THIS CONFERENCE waS CO-SPONSORED BY: AABB, ISBT, DGTI, SFTS, SIMTI AND EBA
The American Association of Blood Banks (AABB) is the global leader in standards development, accreditation and implementation of quality systems in transfusion medicine and cellular therapies. AABB has an unwavering focus on donor and patient safety. AABB accomplish this by translating knowledge into solutions that shape the field of transfusion medicine and cellular therapies.
The International Society of Blood Transfusion (ISBT) is an international society where transfusion medicine professionals from across the globe come together and do the one thing they do best: share knowledge to improve the safety of blood transfusion worldwide. The ISBT believes that with the power of knowledge it can improve the safety of blood transfusion worldwide.
The Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI) is a non-profit organisation promoting transfusion medicine and the development of cooperation with specialist areas, particularly in the fields of science, research and public health. The DGTI serves as an international scientific “umbrella company” in the German-speaking world, has more than 1000 members. In addition to the annual scientific congress with an industrial fair, which presents current developments and research results in transfusion medicine and its border areas, current problems of individual sub-areas are addressed in eight sections. DGTI also supports various programs for the promotion of young professionals, scientific events and basic research.
The French Society of Blood Transfusion (SFTS) is a non-profit organization founded in 1938. SFTS promotes blood transfusion and hemobiology in the scientific, technological, ethical, medico-social and educational level. Its means of action are scientific meetings, national congresses, scientific and technical publications. The SFTS responds to requests from the public authorities or their representatives concerning medical or scientific developments having implications for daily practice. SFTS is committed to Continuing Professional Development and working with related organizations to develop and support
programs for the various professions in the field.
The Società Italiana di Medicina Trasfusionale e Immunoematologia
(SIMTI) was founded in 1954 with the aim to develop knowledge in the field of Transfusion Medicine and Immunohaematology in cooperation with other medical disciplines and supporting voluntary and non-remunerated blood donors and their associations. SIMTI founded the International Scientific Journal “Blood Transfusion” and is also partner of Italian competent Authorities, namely the Ministry of Health and the National Blood Center, in improve the Italian Transfusional Network cooperating for national and international activities. SIMTI has around 2,000 members and affiliates (doctors, biologists, technicians and nurses) working in the Italian Transfusion Services.
The European Blood Alliance (EBA) is an association of non-profit Blood Establishments, with 26 members throughout the European Union and EFTA States. Its mission is to contribute to the safety, security and cost effectiveness
of the blood and tissue and cell supply for the citizens of Europe by developing and maintaining an efficient and strong collaboration amongst European blood and tissue and cell services.
The Centre for Evidence-Based Practice (CEBaP) is a non-profit global centre located in Belgium and supporting humanitarian activities, including those of the Belgian Red Cross, with scientific evidence. CEBaP was launched in 2009 and currently consists of 8 researchers. They provide a scientific basis for a wide range of humanitarian activities, from blood supply to development programs or emergency relief. This is achieved by developing systematic reviews, which are overviews of evidence based on published scientific studies. In addition they develop evidence-based guidelines, in which also practice experience and preferences of the target group are taken into account. Where gaps in evidence are identified, CEBaP also conducts primary field studies.
WITH THE PARTICIPATION OF
Australian Red Cross Blood Service (ARCBS)
Canadian Blood Services (CBS)
International Collaboration for Transfusion Medicine Guidelines (ICTMG)
International Society on Thrombosis and Haemostasis (ISTH)
National Blood Authority, Australia (NBA)
Österreichische Gesellschaft für Blutgruppenserologie, Transfusionsmedizin, Regenerative Medizin und Immungenetik (ÖGBT)
French Society of Anesthesia and Critical Care (SFAR)
IN the presence of
Directorate-General for Health and Food Safety of the European Commission (DG SANTE)